Anne Boulay

4.7k total citations
57 papers, 3.3k citations indexed

About

Anne Boulay is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Anne Boulay has authored 57 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Neurology and 12 papers in Cancer Research. Recurrent topics in Anne Boulay's work include Barrier Structure and Function Studies (13 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Connexins and lens biology (8 papers). Anne Boulay is often cited by papers focused on Barrier Structure and Function Studies (13 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Connexins and lens biology (8 papers). Anne Boulay collaborates with scholars based in France, Switzerland and United Kingdom. Anne Boulay's co-authors include Heidi A. Lane, Terence O’Reilly, Martine Cohen‐Salmon, George Thomas, Sabine Zumstein-Mecker, Nancy E. Hynes, Frédéric Zilbermann, Iwan Beuvink, Bruno Saubaméa and Stephan Ruetz and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Anne Boulay

55 papers receiving 3.2k citations

Peers

Anne Boulay
Benno Küsters Netherlands
Fengju Chen United States
Rui Bi China
Shalom Avraham United States
Alessandro Fatatis United States
Lionel M.L. Chow United States
Daniel Martínez United States
Anne Boulay
Citations per year, relative to Anne Boulay Anne Boulay (= 1×) peers Sueli Mieko Oba‐Shinjo

Countries citing papers authored by Anne Boulay

Since Specialization
Citations

This map shows the geographic impact of Anne Boulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Boulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Boulay more than expected).

Fields of papers citing papers by Anne Boulay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Boulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Boulay. The network helps show where Anne Boulay may publish in the future.

Co-authorship network of co-authors of Anne Boulay

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Boulay. A scholar is included among the top collaborators of Anne Boulay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Boulay. Anne Boulay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen‐Salmon, Martine, et al.. (2025). Development of perivascular astrocyte processes. Frontiers in Neuroscience. 19. 1585340–1585340. 3 indexed citations
2.
Rancillac, Armelle, et al.. (2024). Sclérose en plaques, les espoirs de la recherche. médecine/sciences. 40(10). 770–773. 1 indexed citations
3.
Moch, Clara, Elena Dossi, Giampaolo Milior, et al.. (2023). The ribosome-associated protein RACK1 represses Kir4.1 translation in astrocytes and influences neuronal activity. Cell Reports. 42(5). 112456–112456. 12 indexed citations
4.
Gilbert, Alice, Armelle Rancillac, Audrey Chagnot, et al.. (2022). In mice and humans, brain microvascular contractility matures postnatally. Brain Structure and Function. 228(2). 475–492. 7 indexed citations
5.
Fouet, Agnès, Guillaume Bouvier, Abdelouhab Bouaboud, et al.. (2021). CC17 group B Streptococcus exploits integrins for neonatal meningitis development. Journal of Clinical Investigation. 131(5). 34 indexed citations
6.
Tortuyaux, Romain, et al.. (2020). AstroDot – a new method for studying the spatial distribution of mRNA in astrocytes. Journal of Cell Science. 133(7). 15 indexed citations
7.
Mazaré, Noémie, Julien Moulard, Giselle Cheung, et al.. (2020). Local Translation in Perisynaptic Astrocytic Processes Is Specific and Changes after Fear Conditioning. Cell Reports. 32(8). 108076–108076. 49 indexed citations
8.
Boulay, Anne, Noémie Mazaré, Bruno Saubaméa, & Martine Cohen‐Salmon. (2019). Preparing the Astrocyte Perivascular Endfeet Transcriptome to Investigate Astrocyte Molecular Regulations at the Brain–Vascular Interface. Methods in molecular biology. 1938. 105–116. 10 indexed citations
9.
Chakravarthy, Usha, Dietmar Schwab, Patrick G. Cech, et al.. (2016). The novel bispecific monoclonal anti-VEGF/anti-Ang2 antibody RG7716 shows promise in wet age-related macular degeneration patients with suboptimal response to prior anti-VEGF monotherapy. Investigative Ophthalmology & Visual Science. 57(12). 1 indexed citations
10.
Boulay, Anne, Aurélien Mazeraud, Salvatore Cisternino, et al.. (2015). Immune Quiescence of the Brain Is Set by Astroglial Connexin 43. Journal of Neuroscience. 35(10). 4427–4439. 56 indexed citations
11.
Boulay, Anne, Francisco Castillo, Fabrice Giraudet, et al.. (2013). Hearing Is Normal without Connexin30. Journal of Neuroscience. 33(2). 430–434. 67 indexed citations
12.
Ezan, Pascal, Pascal André, Salvatore Cisternino, et al.. (2012). Deletion of Astroglial Connexins Weakens the Blood–Brain Barrier. Journal of Cerebral Blood Flow & Metabolism. 32(8). 1457–1467. 177 indexed citations
13.
Boulay, Anne, Christophe Bosc, Christian Delphin, et al.. (2012). Bmcc1s, a Novel Brain-Isoform of Bmcc1, Affects Cell Morphology by Regulating MAP6/STOP Functions. PLoS ONE. 7(4). e35488–e35488. 15 indexed citations
14.
Lane, Heidi A., Jeanette M. Wood, Paul M.J. McSheehy, et al.. (2009). mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor. Clinical Cancer Research. 15(5). 1612–1622. 196 indexed citations
15.
Boulay, Anne, Madlaina Breuleux, Christine Stephan, et al.. (2008). The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ERα Pathway in Breast Cancer. Cancer Research. 68(10). 3743–3751. 92 indexed citations
16.
Boulay, Anne & Heidi A. Lane. (2007). The Mammalian Target of Rapamycin Kinase and Tumor Growth Inhibition. PubMed. 172. 99–124. 28 indexed citations
17.
Hynes, Nancy E. & Anne Boulay. (2006). The mTOR Pathway in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 11(1). 53–61. 35 indexed citations
18.
O’Reilly, Terence, Jeanette M. Wood, Amanda Littlewood-Evans, et al.. (2005). Differential anti-vascular effects of mTOR or VEGFR pathway inhibition: A rational basis for combining RAD001 and PTK787/ZK222584. Cancer Research. 65. 715–715. 9 indexed citations
19.
Beuvink, Iwan, Anne Boulay, Stefano Fumagalli, et al.. (2005). The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation. Cell. 120(6). 747–759. 426 indexed citations
20.
Boulay, Anne, et al.. (2004). The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma. Cancer Research. 64. 1298–1298. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026